Nasdaq · CIK 0001571934
TAOX TAO Synergies Inc.
Insider trading from SEC Form 4. Last filing May 19, 2026.
TAO Synergies Inc. (TAOX) has 19 SEC Form 4 filings on file from 7 insiders, the latest filed on May 19, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at TAO Synergies Inc., scored.
Transactions
Every row filed, 34 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 18, 2026 | Robert Ephron director | AGrant or award Stock Option (Right to Buy)derivative | +10,000 | $0.00 | $0 | 10,000 | May 19, 2026 |
| May 18, 2026 | Bruce Bernstein director | AGrant or award Stock Option (Right to Buy)derivative | +55,000 | $0.00 | $0 | 55,000 | May 19, 2026 |
| Apr 7, 2026 | Bruce Bernstein director | AGrant or award Stock Option (Right to Buy)derivative | +800 | $0.00 | $0 | 800 | Apr 8, 2026 |
| Apr 7, 2026 | Robert Ephron director | AGrant or award Stock Option (Right to Buy)derivative | +800 | $0.00 | $0 | 800 | Apr 8, 2026 |
| Oct 17, 2025 | Bruce Bernstein director | AGrant or award Common Stock, par value $0.0001 per share | +25,000 | $0.00 | $0 | 40,897 | Oct 17, 2025 |
| Oct 17, 2025 | Robert Ephron director | AGrant or award Common Stock, par value $0.0001 per share | +7,500 | $0.00 | $0 | 7,500 | Oct 17, 2025 |
| Oct 17, 2025 | Joshua Silverman Executive Chairman | AGrant or award Common Stock, par value $0.0001 per share | +100,000 | $0.00 | $0 | 126,681 | Oct 17, 2025 |
| Oct 17, 2025 | William S. Singer director | AGrant or award Common Stock, par value $0.0001 per share | +15,000 | $0.00 | $0 | 25,566 | Oct 17, 2025 |
| Oct 17, 2025 | Robert Weinstein Chief Financial Officer | AGrant or award Common Stock, par value $0.0001 per share | +10,000 | $0.00 | $0 | 20,574 | Oct 17, 2025 |
| Aug 6, 2025 | Jonathan Schechter director | AGrant or award Employee Stock Option (right to buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Oct 17, 2025 |
| Oct 17, 2025 | Bruce Bernstein director | FTax withholding Common Stock, par value $0.0001 per share | -10,000 | $7.23 | $72k | 30,897 | Oct 17, 2025 |
| Oct 17, 2025 | Robert Ephron director | FTax withholding Common Stock, par value $0.0001 per share | -3,000 | $7.23 | $22k | 4,500 | Oct 17, 2025 |
| Oct 17, 2025 | Joshua Silverman Executive Chairman | FTax withholding Common Stock, par value $0.0001 per share | -40,000 | $7.23 | $289k | 86,681 | Oct 17, 2025 |
| Oct 17, 2025 | William S. Singer director | FTax withholding Common Stock, par value $0.0001 per share | -6,000 | $7.23 | $43k | 19,566 | Oct 17, 2025 |
| Oct 17, 2025 | Robert Weinstein Chief Financial Officer | FTax withholding Common Stock, par value $0.0001 per share | -4,000 | $7.23 | $29k | 16,574 | Oct 17, 2025 |
| Aug 6, 2025 | Robert Weinstein Chief Financial Officer | AGrant or award Employee Stock Option (right to buy)derivative | +7,000 | $0.00 | $0 | 7,000 | Oct 17, 2025 |
| Aug 6, 2025 | William S. Singer director | AGrant or award Employee Stock Option (right to buy)derivative | +7,000 | $0.00 | $0 | 7,000 | Oct 17, 2025 |
| Aug 6, 2025 | Bruce Bernstein director | AGrant or award Employee Stock Option (right to buy)derivative | +12,000 | $0.00 | $0 | 12,000 | Oct 17, 2025 |
| Aug 6, 2025 | Joshua Silverman Executive Chairman | AGrant or award Employee Stock Option (right to buy)derivative | +36,000 | $0.00 | $0 | 36,000 | Oct 17, 2025 |
| Jun 30, 2025 | William S. Singer director | AGrant or award Common Stock, par value $0.0001 per share | +15,410 | $0.00 | $0 | 16,730 | Jul 2, 2025 |
| Jun 30, 2025 | Robert Weinstein Chief Financial Officer | AGrant or award Common Stock, par value $0.0001 per share | +15,410 | $0.00 | $0 | 16,738 | Jul 2, 2025 |
| Jun 30, 2025 | Alan J Tuchman Chief Medical Officer | AGrant or award Common Stock, par value $0.0001 per share | +4,315 | $0.00 | $0 | 5,635 | Jul 2, 2025 |
| Jun 30, 2025 | Joshua Silverman Executive Chairman | AGrant or award Common Stock, par value $0.0001 per share | +41,919 | $0.00 | $0 | 43,449 | Jul 2, 2025 |
| Jun 30, 2025 | Jonathan Schechter director | AGrant or award Common Stock, par value $0.0001 per share | +21,575 | $0.00 | $0 | 22,665 | Jul 2, 2025 |
| Jun 30, 2025 | Bruce Bernstein director | AGrant or award Common Stock, par value $0.0001 per share | +24,657 | $0.00 | $0 | 25,760 | Jul 2, 2025 |
| Jun 30, 2025 | Jonathan Schechter director | FTax withholding Common Stock, par value $0.0001 per share | -8,630 | $7.85 | $68k | 14,035 | Jul 2, 2025 |
| Jun 30, 2025 | Joshua Silverman Executive Chairman | FTax withholding Common Stock, par value $0.0001 per share | -16,768 | $7.85 | $132k | 26,681 | Jul 2, 2025 |
| Jun 30, 2025 | William S. Singer director | FTax withholding Common Stock, par value $0.0001 per share | -6,164 | $7.85 | $48k | 10,566 | Jul 2, 2025 |
| Jun 30, 2025 | Bruce Bernstein director | FTax withholding Common Stock, par value $0.0001 per share | -9,863 | $7.85 | $77k | 15,897 | Jul 2, 2025 |
| Jun 30, 2025 | Alan J Tuchman Chief Medical Officer | FTax withholding Common Stock, par value $0.0001 per share | -1,726 | $7.85 | $14k | 3,909 | Jul 2, 2025 |
| Jun 30, 2025 | Robert Weinstein Chief Financial Officer | FTax withholding Common Stock, par value $0.0001 per share | -6,164 | $7.85 | $48k | 10,574 | Jul 2, 2025 |
| Apr 3, 2025 | Bruce Bernstein director | AGrant or award Stock Option (Right to Buy)derivative | +800 | $0.00 | $0 | 800 | Apr 7, 2025 |
| Apr 3, 2025 | Jonathan Schechter director | AGrant or award Stock Option (Right to Buy)derivative | +800 | $0.00 | $0 | 800 | Apr 7, 2025 |
| Apr 3, 2025 | William S. Singer director | AGrant or award Stock Option (Right to Buy)derivative | +800 | $0.00 | $0 | 800 | Apr 7, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Bruce Bernsteindirector
- Robert Ephrondirector
- Jonathan Schechterdirector
- Joshua SilvermanExecutive Chairman
- William S. Singerdirector
- Alan J TuchmanChief Medical Officer
- Robert WeinsteinChief Financial Officer
Questions about TAOX
Answered from the filings on this page, as of the latest one.
Are insiders buying TAOX?
No. In the last 90 days no insider at TAO Synergies Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade TAOX on the open market?
No open-market trade has been scored at TAO Synergies Inc.. The latest Form 4 on file was filed on May 19, 2026 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at TAO Synergies Inc.?
7 people have filed a Form 4 at TAO Synergies Inc., among them Bruce Bernstein (director), Robert Ephron (director), Jonathan Schechter (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.